1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
Registry marked status Unknown (sponsor has not verified the record since Jan 2024); last known: Not Yet Recruiting
The First People's Hospital of ChangzhouPhase 4 NCT06216340 Registry history of NCT06216340 on ClinicalTrials.gov (opens the registry)
Changed
| Phase 1 | 1 | |
| Phase 1/2 | 2 | |
| Phase 2 | 12 | |
| Phase 2/3 | 1 | |
| Phase 3 | 1 | |
| Phase 4 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT02496988 | Effect of Cytokine-induced Killer Cells for Advanced Malignant Gliomas | Cytokine-Induced Killer Cells | Not Yet Recruiting | 2015-07-14 |
| Phase 3 | ||||
| NCT06867991 | Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune… | Anti-N-Methyl-D-Aspartate Receptor Encephalitis | Recruiting | 2026-06-09 |
| Phase 2/3 | ||||
| NCT02482454 | Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With… | Cholangiocarcinoma | Active, Not Recruiting | 2017-08-01 |
| Phase 2 | ||||
| NCT05732662 | SBRT Combined With AK104 to Treatment Relapsed or Metastatic ESCC | Recurrent or Metastatic Esophageal Squamous Cell Carcinoma | Not Yet Recruiting | 2023-02-17 |
| NCT02487992 | The Study of CIK Plus S-1 and Bevacizumab as Maintenance Treatment for Patients With… | Colorectal Neoplasms | Active, Not Recruiting | 2016-02-24 |
| NCT02487693 | Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With… | Ovarian Carcinoma | Active, Not Recruiting | 2016-02-23 |
| NCT02490748 | Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With… | Cervical Cancer | Active, Not Recruiting | 2016-02-23 |
| NCT02491697 | Immunotherapy Combined With Capecitabine Versus Capecitabine Monotherapy in Advanced… | Breast Cancer | Active, Not Recruiting | 2016-02-23 |
| NCT02489890 | CIK in Treating Patients With Bladder Cancer | Urinary Bladder Neoplasms | Active, Not Recruiting | 2016-02-22 |
| NCT02485015 | The Study of Apatinib Plus CIK as the Third Line Therapy for Patients With Advanced… | Stomach Neoplasms | Active, Not Recruiting | 2016-02-19 |
| NCT02493582 | The Study of Apatinib Plus CIK as the Third Line Therapy for Advanced Lung Adenocarcinoma… | Adenocarcinoma of Lung | Active, Not Recruiting | 2016-02-05 |
| NCT02497898 | Treatment of CIK for Patients With Refractory Non-Hodgkin Lymphoma | Lymphoma, Non-Hodgkin | Not Yet Recruiting | 2015-07-15 |
| NCT02498756 | Cytokine-induced Killer Study for Patients With Stage II Melanoma | Melanoma | Not Yet Recruiting | 2015-07-15 |
| NCT02490735 | CIK in Treating Patients With Esophageal Cancer | Esophageal Squamous Cell Carcinoma | Not Yet Recruiting | 2015-07-07 |
| NCT02487550 | DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating | Renal Neoplasma | Not Yet Recruiting | 2015-07-01 |
| Phase 1/2 | ||||
| NCT07769671 | Human Umbilical Cord Mesenchymal Stem Cell Infusion for Type 2 Diabetic Nephropathy | Diabetic Nephropathy Type 2 | Not Yet Recruiting | 2026-08-18 |
| NCT02494804 | Effect of Cytokine-induced Killer Cells for Stage I-II Malignant Gliomas | Cytokine-Induced Killer Cells | Not Yet Recruiting | 2015-07-10 |
| Phase 1 | ||||
| NCT02496273 | Phase I Trial of CEA Specific AAV-DC-CTL Treatment in Stage IV Gastric Cancer | Gastric Cancer | Active, Not Recruiting | 2016-02-22 |
| Not applicable | ||||
| NCT06456515 | Regorafenib and Sintilimab in Combination with Electroacupuncture in MSS CRC | Colorectal Cancer Metastatic | Recruiting | 2025-02-17 |
| NCT06950242 | Clinical Trial of Safety and Efficacy of Intracranial Laser Balloon Dilation Catheter in… | Prospective, Multicenter, Randomized, Controlled, and Superior Efficiency | Enrolling by Invitation | 2025-04-30 |
Colorectal Cancer (2) · Esophageal Cancer (2) · Gastric Cancer (2) · Glioma (2) · Bladder Cancer (1) · Breast Cancer (1) · Cervical Cancer (1) · Cholangiocarcinoma (1) · Kidney Cancer (1) · Lung Cancer (1)